U.S. market Closed. Opens in 1 day 6 hours 57 minutes

INM | InMed Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-30
Revenue4.60M4.14M1.09MN/AN/A
Cost of Revenue3.50M2.73M545.89K197.03K183.09K
Gross Profit1.10M1.40M543.55K-197.03K-183.09K
Operating Expenses9.02B9.78M14.34M9.94M8.87M
Selling, General & Admin5.25M5.85M6.87M4.48M3.50M
Research & Development3.77M3.73M7.28M5.34M5.20M
Other Operating ExpensesN/A-308.94K185.66K120.87K161.97K
Operating IncomeN/A-8.18B-13.70M-9.92M-8.74M
Other Expenses / Income246.38M588.53K-1.10M2.12M60.73K
Before Tax Income-7.67M-7.93M-18.60M-10.20M-8.68M
Income Tax Expenses7.10K13.10K4.81M360.35K18.62K
Net Income-7.68M-7.95M-18.60M-10.20M-8.94M
Interest ExpensesN/AN/A96.09K360.35K18.62K
Basic Shares Outstanding7.59M2.45M560.75K270.00K210.00K
Diluted Shares Outstanding7.59M2.45M560.83K270.00K210.00K
EBITDA-7.06M-10.83M-17.26M-9.80M-8.58M
EBITDA Margin-153.64%-261.92%-1,584.07%0.00%0.00%
EBIT-7.67M-7.93M-13.70M-9.48M-8.90M
EBIT Margin-166.79%-191.86%-1,257.13%0.00%0.00%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙